$2.41 Billion is the total value of NEA Management Company, LLC's 43 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TSRO | TESARO INC | $851,499,000 | -35.8% | 10,275,113 | 0.0% | 35.27% | -24.1% | |
| GLYC | GLYCOMIMETICS INC | $144,128,000 | +20.0% | 8,584,128 | 0.0% | 5.97% | +42.0% | |
| RYTM | New | RHYTHM PHARMACEUTICALS INC | $142,752,000 | – | 4,912,306 | +100.0% | 5.91% | – |
| MRSN | MERSANA THERAPEUTICS INC | $133,810,000 | -5.0% | 8,144,267 | 0.0% | 5.54% | +12.4% | |
| DERM | DERMIRA INC | $97,520,000 | +3.0% | 3,506,649 | 0.0% | 4.04% | +21.8% | |
| ARDX | ARDELYX INC | $92,952,000 | +17.9% | 14,083,582 | 0.0% | 3.85% | +39.4% | |
| SENS | Sell | SENSEONICS HOLDINGS INC | $82,163,000 | -22.9% | 30,888,266 | -7.6% | 3.40% | -8.9% |
| EPZM | EPIZYME INC | $81,084,000 | -34.1% | 6,460,851 | 0.0% | 3.36% | -22.1% | |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCadr | $80,334,000 | -18.4% | 12,025,999 | 0.0% | 3.33% | -3.5% | |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $75,623,000 | +31.4% | 3,220,728 | 0.0% | 3.13% | +55.4% | |
| AKAOQ | ACHAOGEN INC | $56,010,000 | -32.7% | 5,215,128 | 0.0% | 2.32% | -20.4% | |
| AVEO | AVEO PHARMACEUTICALS INC | $45,652,000 | -23.6% | 16,362,694 | 0.0% | 1.89% | -9.6% | |
| IMMU | IMMUNOMEDICS INC | $44,806,000 | +15.6% | 2,772,643 | 0.0% | 1.86% | +36.7% | |
| OBSV | Buy | OBSEVA SA | $44,765,000 | +64.8% | 4,586,563 | +37.5% | 1.85% | +95.0% |
| CMTA | CLEMENTIA PHARMACEUTICALS IN | $40,649,000 | +12.4% | 2,141,697 | 0.0% | 1.68% | +32.9% | |
| SYBX | SYNLOGIC INC | $37,048,000 | -49.0% | 3,819,410 | 0.0% | 1.54% | -39.7% | |
| CASC | CASCADIAN THERAPEUTICS INC | $33,539,000 | -9.5% | 9,064,575 | 0.0% | 1.39% | +6.9% | |
| PTI | Buy | PROTEOSTASIS THERAPEUTICS INC | $32,396,000 | +333.7% | 5,556,778 | +56.2% | 1.34% | +412.2% |
| SBBP | STRONGBRIDGE BIOPHARMA PLC | $30,024,000 | +5.1% | 4,141,308 | 0.0% | 1.24% | +24.3% | |
| RARX | RA PHARMACEUTICALS INC | $29,696,000 | -41.8% | 3,493,636 | 0.0% | 1.23% | -31.2% | |
| TNTRQ | TINTRI INC | $26,792,000 | +62.4% | 5,253,358 | 0.0% | 1.11% | +92.0% | |
| ASNS | New | ARSANIS INC | $25,520,000 | – | 2,000,000 | +100.0% | 1.06% | – |
| LXRX | LEXICON PHARMACEUTICALS INC | $23,537,000 | -19.6% | 2,382,286 | 0.0% | 0.98% | -4.9% | |
| AUPH | AURINIA PHARMACEUTICALS INC | $21,782,000 | -27.8% | 4,808,483 | 0.0% | 0.90% | -14.6% | |
| VRNA | VERONA PHARMA PLCads | $14,478,000 | -22.7% | 1,219,674 | 0.0% | 0.60% | -8.5% | |
| ERYP | New | ERYTECH PHARMA SAadr | $13,763,000 | – | 625,000 | +100.0% | 0.57% | – |
| ELGX | ENDOLOGIX INC | $13,323,000 | +20.0% | 2,490,204 | 0.0% | 0.55% | +41.9% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $12,583,000 | +52.7% | 3,243,150 | 0.0% | 0.52% | +80.3% | |
| RGLS | REGULUS THERAPEUTICS INC | $11,430,000 | -16.8% | 10,989,910 | 0.0% | 0.47% | -1.5% | |
| NITE | NIGHTSTAR THERAPEUTICS PLCadr | $9,371,000 | -31.7% | 714,285 | 0.0% | 0.39% | -19.2% | |
| TCON | TRACON PHARMACEUTICALS INC | $9,243,000 | +6.3% | 2,759,217 | 0.0% | 0.38% | +26.0% | |
| Buy | TRILLIUM THERAPEUTICS INC | $9,063,000 | +67.6% | 1,250,000 | +19.0% | 0.38% | +98.4% | |
| DZSI | DASAN ZHONE SOLUTIONS INC | $8,855,000 | +35.6% | 956,255 | 0.0% | 0.37% | +60.3% | |
| TRVN | TREVENA INC | $6,099,000 | -37.3% | 3,811,691 | 0.0% | 0.25% | -25.6% | |
| CSBR | CHAMPIONS ONCOLOGY INC | $6,063,000 | +5.7% | 1,562,500 | 0.0% | 0.25% | +24.9% | |
| AFMD | AFFIMED NV | $5,056,000 | -42.2% | 3,888,888 | 0.0% | 0.21% | -31.7% | |
| SNSS | SUNESIS PHARMACEUTICALS INC | $4,791,000 | +90.2% | 1,298,274 | 0.0% | 0.20% | +125.0% | |
| MDB | New | MONGODB INCcl a | $4,452,000 | – | 150,000 | +100.0% | 0.18% | – |
| ARQL | ARQULE INC | $4,159,000 | +48.6% | 2,520,316 | 0.0% | 0.17% | +75.5% | |
| AQ | New | AQUANTIA | $2,715,000 | – | 239,587 | +100.0% | 0.11% | – |
| ABIO | ARCA BIOPHARMA INC | $1,971,000 | +17.4% | 1,460,209 | 0.0% | 0.08% | +39.0% | |
| AKTX | AKARI THERAPEUTICS PLCadr | $1,958,000 | -29.5% | 452,167 | 0.0% | 0.08% | -16.5% | |
| OREXQ | OREXIGEN THERAPEUTICS INC | $478,000 | -39.2% | 370,900 | 0.0% | 0.02% | -28.6% | |
| CBIO | Exit | CATALYST BIOSCIENCES INC | $0 | – | -43,492 | -100.0% | -0.01% | – |
| CERC | Exit | CERECOR INC | $0 | – | -595,435 | -100.0% | -0.02% | – |
| ROKA | Exit | ROKA BIOSCIENCE INC | $0 | – | -893,471 | -100.0% | -0.02% | – |
| PXLW | Exit | PIXELWORKS INC | $0 | – | -359,555 | -100.0% | -0.06% | – |
| SCMP | Exit | SUCAMPO PHARMACEUTICALS INCcl a | $0 | – | -1,258,507 | -100.0% | -0.52% | – |
| CRCM | Exit | CARE COM INC | $0 | – | -3,260,989 | -100.0% | -1.82% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GLYCOMIMETICS INC | 39 | Q3 2023 | 7.6% |
| AURINIA PHARMACEUTICALS INC | 37 | Q3 2023 | 5.0% |
| CHAMPIONS ONCOLOGY INC | 33 | Q3 2023 | 1.2% |
| LEXICON PHARMACEUTICALS INC | 32 | Q3 2023 | 2.0% |
| ADAPTIMMUNE THERAPEUTICS PLC | 31 | Q3 2023 | 9.3% |
| TREVENA INC | 31 | Q3 2021 | 3.3% |
| AKARI THERAPEUTICS PLC | 31 | Q2 2023 | 0.3% |
| ARDELYX INC | 29 | Q3 2021 | 11.9% |
| RIGEL PHARMACEUTICALS INC | 29 | Q2 2020 | 0.6% |
| EPIZYME INC | 28 | Q1 2020 | 9.6% |
View NEA Management Company, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
View NEA Management Company, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.